Atezolizumab vs Empagliflozin

## Atezolizumab vs Empagliflozin: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Empagliflozin**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Empagliflozin — 12.4 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Empagliflozin — C23H27ClO7.

**Molecular Weight**: Atezolizumab — N/A; Empagliflozin — 450.9100 g/mol.

**Type**: Atezolizumab — Antibody; Empagliflozin — Small molecule.